Insider holders · CIK 0001671502
Quoin Pharmaceuticals, Ltd. · QNRX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Dennis LangerDirector | 56,243 | — | 56,243 | Aug 28, 2026 · 6:40 pm EDT | Form 4 |
| Anthony James CulverwellDirector | 40,364 | — | 40,364 | Sep 1, 2026 · 9:38 pm EDT | Form 4 |
| Michael MyersChief Executive Officer | 37,713 | — | 37,713 | Sep 1, 2026 · 9:39 pm EDT | Form 4 |
| Denise P. CarterChief Operating Officer | 37,709 | — | 37,709 | Sep 1, 2026 · 9:40 pm EDT | Form 4 |
| Sally Bridget LawlorChief Financial Officer | 10,684 | — | 10,684 | Sep 1, 2026 · 9:39 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.